Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal: a Multi-center, Randomized, Open-labelled, Phase III Clinical Trial

NCT04694612 is registered in ClinicalTrials.gov with Nepal Health Research Council as lead sponsor.

NCT NCT04694612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04694612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal: a Multi-center, Randomized, Open-labelled, Phase III Clinical Trial
Lead sponsor
Nepal Health Research Council
Phase
Phase 3
Overall status
Unknown status
Start date
January 1, 2021
Completion date
May 31, 2021
Enrollment
676 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid19